Effectiveness of Narrative Medicine on Pain Intensity and Quality of Life
1 other identifier
interventional
210
1 country
1
Brief Summary
Narrative medicine addresses the therapeutic benefits that derive from patients forming and telling their personal stories. It offers an innovative model for improving health outcomes. When a patient with cancer and marked suffering writes a narrative of what he or she is going through, this process may reduce pain and improve quality of life. Therefore, we seek to evaluate the effectiveness of writing a narrative on pain intensity and health related quality of life. We propose a randomized single blind (evaluator) controlled trial. Patients with cancer pain of intensity at least 5/10 with a minimum Karnofsky score of 50% will be randomized into three groups: 1. Narrative group. Patients will write a story about their illness for at least 20 minutes once a week for 3 weeks; 2. Writing-control group. Patients will fill a pain diary once a week for three weeks; 3. Control group. Subjects will not write/fill anything. Pain will be evaluated using the numerical scale before randomization and then weekly for 8 weeks. We will also evaluate how pain interferes with general activity, mood, work, relation with others, sleep, and enjoyment of life using the Brief Pain Inventory. As secondary outcomes, we will evaluate health related quality of life, with the treatment outcomes of pain survey, which is a modification of the SF 36 (short form health survey), and a global measure of well-being before randomization, and then at 4 and 8 weeks. We will also evaluate the emotional disclosure of the narratives. We will use an intention to treat analysis. To analyze the effect of the treatment on pain intensity, quality of life, and well-being, we will employ an analysis of repeated measures using generalized estimating equations. We will include in the regression models the treatment group, the emotional disclosure score, the time, and the interaction between treatment group and time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Jan 2004
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
March 29, 2005
CompletedFirst Posted
Study publicly available on registry
March 30, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2006
CompletedMarch 20, 2008
March 1, 2005
March 29, 2005
March 19, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity
Secondary Outcomes (2)
Pain interference with general activity, mood, work, relation with others, sleep, and enjoyment of life.
Health related quality of life
Interventions
Eligibility Criteria
You may qualify if:
- Patients with cancer pain of intensity at least 5/10 with a minimum Karnofsky score of 50%
You may not qualify if:
- Patients unable to write or read
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Ignacio Hospital
Bogotá, DC, Colombia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
M. Soledad Cepeda, MD, PhD
Javeriana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 29, 2005
First Posted
March 30, 2005
Study Start
January 1, 2004
Study Completion
August 1, 2006
Last Updated
March 20, 2008
Record last verified: 2005-03